Karki, Chitra http://orcid.org/0000-0001-9336-7589
Latremouille-Viau, Dominick
Gilaberte, Inmaculada http://orcid.org/0000-0002-3811-9811
Hantsbarger, Gary
Romdhani, Hela http://orcid.org/0000-0001-5219-2612
Lightner, Amy L. http://orcid.org/0000-0002-0459-0699
Funding for this research was provided by:
Takeda Pharmaceuticals
Article History
Accepted: 11 May 2023
First Online: 4 August 2023
Declarations
:
: This work was supported by Takeda Pharmaceuticals. Medical writing support was provided by Sally McTaggart, PhD, of Oxford Pharmagenesis, Oxford, UK and was funded by Takeda Pharmaceuticals.
: Chitra Karki is an employee and shareholder of Takeda Pharmaceuticals USA, Inc. Dominick Latremouille-Viau is an employee of Analysis Group, Inc., a company which received funding from Takeda Pharmaceuticals USA, Inc. for this study. Inmaculada Gilaberte is an employee of Takeda Madrid, Cell Therapy Technology Center. Gary Hantsbarger is an employee and shareholder of Takeda Pharmaceuticals USA, Inc. Hela Romdhani is an employee of Analysis Group, Inc., a company which received funding from Takeda Pharmaceuticals USA, Inc. for this study. Amy L Lightner was an employee of Cleveland Clinic at the time of this study, is a consultant for Takeda, Ossium Health, Mesoblast Inc, and Boomerang Health, and is Chief Medical Officer at Direct Biologics.
: Not applicable: this was a non-interventional retrospective study. All data collected from the US administrative claims databases were de-identified and comply with the confidentiality requirements of the Health Insurance Portability and Accountability Act.
: Not applicable: all data were collected retrospectively from administrative claims databases and de-identified.
: Not applicable: all data were collected retrospectively from administrative claims databases and de-identified.
: The data that support the findings of this study are derived from Truven Health MarketScan<sup>®</sup>. Restrictions apply to the availability of these data, which were used under license for this study. Data are available from the authors with the permission of Truven Health MarketScan<sup>®</sup>.
: Not applicable.
: All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Dominick Latremouille-Viau and Hela Romdhani. All authors contributed to the previous versions of the manuscript and approved the final manuscript.
: Some findings in this article were previously presented at the ECCO 2021 virtual congress, 8–10 July 2021.
: This was a non-interventional retrospective study. All data collected from the US administrative claims databases were de-identified and comply with the confidentiality requirements of the Health Insurance Portability and Accountability Act.